Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Bone & Joint Health Supplements Market

Bone & Joint Health Supplements Market Trends

Report ID: GMI7684
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Bone & Joint Health Supplements Market Trends

As the global population ages, the prevalence of age-related health issues, including bone and joint disorders increases. This population is more susceptible to conditions such as osteoporosis, arthritis, and general joint stiffness. Also, the awareness pertaining to the benefits of bone and joint health supplements has grown, leading to an increased adoption of products containing ingredients such as calcium, vitamin D, vitamin K, glucosamine, collagen supplement, and others.
Additionally, the market has witnessed a surge in innovative delivery formulations beyond traditional tablets and capsules. Gummies, powders, and liquid formulations are becoming more popular, offering consumers diverse options for supplementation.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for bone & joint health supplements was valued at USD 13.6 billion in 2023 and is anticipated to observe over 7.5% CAGR from 2024 to 2032 attributed to the increasing ageing population and the rising prevalence of bone-related disorders.

The vitamins & minerals segment accounted for a significant market share of 50.1% in 2023 and will grow significantly through 2032 as they are easily accessible and affordable, making them more widely available to a diverse consumer base.

North America market size was USD 5.2 billion in 2023 and is expected to expand by 2032 with the growing geriatric population along with the higher prevalence of bone and joint health issues, such as osteoporosis and arthritis.

Bayer AG, Amway, BASF SE, Vita Life Sciences Ltd, Glanbia plc, Arazo Nutrition, Reckitt Benckiser Group plc, Nature's Bounty, Inc., NOW Foods, and GNC Holdings, LLC.